Free Trial

Needham & Company LLC's Rating of Hims & Hers Health on 11/10/2026

On November 10, 2026, Needham & Company LLC updated its outlook on Hims & Hers Health (NYSE:HIMS) with the action "Lower Price Target", setting a price target of $32.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Needham & Company LLC

DateCompanyAction
11/12/2026
Wolverine World Wide, Inc. stock logo
WWW
Wolverine World Wide
Boost Price Target
11/12/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
Lower Price Target
11/12/2026
ODDITY Tech Ltd. stock logo
ODD
ODDITY Tech
Reiterated Rating
11/12/2026
AEVEX Corp. stock logo
AVEX
AEVEX
Lower Price Target
11/12/2026
CuriosityStream Inc. stock logo
CURI
CuriosityStream
Lower Price Target
11/12/2026
Cohu, Inc. stock logo
COHU
Cohu
Reiterated Rating
More Ratings From Needham & Company LLC